Undisclosed Small Molecule Program

About Eikon Therapeutics

Eikon Therapeutics is a next-generation drug discovery company founded by Nobel laureate Dr. Eric Betzig, leveraging breakthrough single-molecule tracking microscopy and AI to visualize and quantify protein movement within living cells. This unique platform aims to identify novel drug targets and develop small molecule therapeutics for complex diseases, particularly in oncology. The company has attracted substantial venture capital and strategic investment, reflecting strong confidence in its technology and approach to tackling historically intractable biological pathways.

About Eikon Therapeutics

Eikon Therapeutics is a next-generation drug discovery company founded by Nobel laureate Dr. Eric Betzig, leveraging breakthrough single-molecule tracking microscopy and AI to visualize and quantify protein movement within living cells. This unique platform aims to identify novel drug targets and develop small molecule therapeutics for complex diseases, particularly in oncology. The company has attracted substantial venture capital and strategic investment, reflecting strong confidence in its technology and approach to tackling historically intractable biological pathways.

Therapeutic Areas